MUSTANG BIO, INC. Prepaid Expense and Other Assets, Current
MUSTANG BIO, INC. (MBIO) had Prepaid Expense and Other Assets, Current of $246.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-05
- 2026-06-30: Prepaid Expense and Other Assets, Current $246.00K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $107.00K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $110.00K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $160.00K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $246.00K 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $107.00K 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $110.00K 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $160.00K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $172.00K 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $211.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $200.00K 10-K · filed 2026-03-19 | |
| 2024-09-30 | $84.00K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $114.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $1.17M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $1.23M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $4.03M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $2.84M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $3.03M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $2.90M 10-K · filed 2024-03-11 | $3.16M 10-K · filed 2023-03-30 |
| 2022-09-30 | $3.05M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.97M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.91M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $2.04M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $1.03M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $1.39M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $1.58M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $1.72M 10-K · filed 2022-03-23 | |
| 2020-09-30 | $344.00K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $886.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $1.88M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.63M 10-K · filed 2021-03-24 | |
| 2019-09-30 | $1.51M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $660.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $857.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $1.05M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |